C18H18N2O6, monoclinic, P21/n (no. 14), a = 7.4809(14) Å, b = 13.082(2) Å, c = 16.870(3) Å, β = 93.440(4)°, V = 1648.0(5) Å3, Z = 4, Rgt(F) = 0.0433, wRref(F2) = 0.1279, T = 296(2) K
The title compound, C10H8N2O2·H2O, consists of an N-hydroxyquinoline-2-carboxamide molecule in the k...
In the anion of the title hydrated molecular salt, C9H8N+·C8H4NO6−·H2O, the protonated carboxyl and ...
C18H19NO3, monoclinic, P121/n1 (No. 14), a = 8.454(6) Å, b= 13.123(3) Å, c = 14.698(3) Å,ß= 104.85(3...
C13H13NO3, monoclinic, C2/c (no. 15), a = 22.886(3) Å, b = 12.763(2) Å, c = 8.175(1) Å, β = 107.756(...
C22H24N2O3, orthorhombic, Pbca (no. 61), a = 15.333(11) Å, b = 14.146(11) Å, c = 17.640(13) Å, V = 3...
C16H13N3O4, monoclinic, C2/c (No. 15), a = 13.8536(12) Å, b = 11.0922(7) Å, c = 20.432(2) Å, β = ...
C18H21NO3S, triclinic, P1̄ (no. 2), a = 7.2345(18) Å, b = 10.842(3) Å, c = 11.573(3) Å, α = 69.174(4...
In the title hydrated salt, C9H8NO+·C8H4NO6−·H2O, the deprotonated carboxylate group is almost norma...
C18H17N3O9, monoclinic, P21/c (no. 14), a = 15.3768(3) Å, b = 7.4510(2) Å, c = 15.6673(5) Å, β = 102...
C19H18N4O, monoclinic, P21/c (no. 14), a = 11.3744(16) Å, b = 13.7367(15) Å, c = 11.208(2) Å, β = 11...
C20H22N2O6, monoclinic, P21/c (no. 14), a = 8.6657(6) Å, b = 18.6201(14) Å, c = 22.3583(18) Å, β = 9...
C22H19NO7, monoclinic, P21/n (no. 14), a = 7.5742(4) Å, b = 20.0688(12) Å, c = 13.2932(8) Å, β = 102...
C22H25NO5, monoclinic, P21/c (no. 14), a = 15.7241(13) Å, b = 7.0223(5) Å, c = 18.4613(14) Å, β = 10...
C12H12N2O6 crystallized from methanol in the monoclinic space group P21/c (Z=4) witha=13.333(4),b=10...
C19H18N2O6, monoclinic, P21/c (no. 14), a = 13.052(8) Å, b = 10.091(6) Å, c = 14.454(9) Å, β = 114.4...
The title compound, C10H8N2O2·H2O, consists of an N-hydroxyquinoline-2-carboxamide molecule in the k...
In the anion of the title hydrated molecular salt, C9H8N+·C8H4NO6−·H2O, the protonated carboxyl and ...
C18H19NO3, monoclinic, P121/n1 (No. 14), a = 8.454(6) Å, b= 13.123(3) Å, c = 14.698(3) Å,ß= 104.85(3...
C13H13NO3, monoclinic, C2/c (no. 15), a = 22.886(3) Å, b = 12.763(2) Å, c = 8.175(1) Å, β = 107.756(...
C22H24N2O3, orthorhombic, Pbca (no. 61), a = 15.333(11) Å, b = 14.146(11) Å, c = 17.640(13) Å, V = 3...
C16H13N3O4, monoclinic, C2/c (No. 15), a = 13.8536(12) Å, b = 11.0922(7) Å, c = 20.432(2) Å, β = ...
C18H21NO3S, triclinic, P1̄ (no. 2), a = 7.2345(18) Å, b = 10.842(3) Å, c = 11.573(3) Å, α = 69.174(4...
In the title hydrated salt, C9H8NO+·C8H4NO6−·H2O, the deprotonated carboxylate group is almost norma...
C18H17N3O9, monoclinic, P21/c (no. 14), a = 15.3768(3) Å, b = 7.4510(2) Å, c = 15.6673(5) Å, β = 102...
C19H18N4O, monoclinic, P21/c (no. 14), a = 11.3744(16) Å, b = 13.7367(15) Å, c = 11.208(2) Å, β = 11...
C20H22N2O6, monoclinic, P21/c (no. 14), a = 8.6657(6) Å, b = 18.6201(14) Å, c = 22.3583(18) Å, β = 9...
C22H19NO7, monoclinic, P21/n (no. 14), a = 7.5742(4) Å, b = 20.0688(12) Å, c = 13.2932(8) Å, β = 102...
C22H25NO5, monoclinic, P21/c (no. 14), a = 15.7241(13) Å, b = 7.0223(5) Å, c = 18.4613(14) Å, β = 10...
C12H12N2O6 crystallized from methanol in the monoclinic space group P21/c (Z=4) witha=13.333(4),b=10...
C19H18N2O6, monoclinic, P21/c (no. 14), a = 13.052(8) Å, b = 10.091(6) Å, c = 14.454(9) Å, β = 114.4...
The title compound, C10H8N2O2·H2O, consists of an N-hydroxyquinoline-2-carboxamide molecule in the k...
In the anion of the title hydrated molecular salt, C9H8N+·C8H4NO6−·H2O, the protonated carboxyl and ...
C18H19NO3, monoclinic, P121/n1 (No. 14), a = 8.454(6) Å, b= 13.123(3) Å, c = 14.698(3) Å,ß= 104.85(3...
DOI
Add to ORKG